GUILFORD PHARMACEUTICALS

Guilford Pharmaceuticals

#SimilarOrganizations #More

GUILFORD PHARMACEUTICALS

Industry:
Biotechnology Health Care Pharmaceutical

Status:
Active


Similar Organizations

not_available_image

Bertek Pharmaceuticals

Bertek Pharmaceuticals

not_available_image

Cann Pharmaceuticals

Cann Pharmaceuticals

not_available_image

CytoTherapeutics

CytoTherapeutics

not_available_image

Lorex Pharmaceuticals

Lorex Pharmaceuticals.

sinco-pharmaceuticals-logo

Sinco Pharmaceuticals

Sinco Pharmaceuticals

sindolor-logo

Sindolor

Develops cannabinoid containing pharmaceuticals

not_available_image

Sirus Pharmaceuticals

Sirus Pharmaceuticals Ltd

More informations about "Guilford Pharmaceuticals"

SECURITIES AND EXCHANGE COMMISSION - SEC.gov

GUILFORD PHARMACEUTICALS INC. AND SUBSIDIARIES Notes to Consolidated Financial Statements June 30, 2000 (unaudited) 1. Organization and Basis of Presentation Guilford โ€ฆSee details»

Guilford Pharmaceuticals - PitchBook

Guilford Pharmaceuticals General Information Description. Operator of integrated biopharmaceutical company. The company is engaged in the research, development and โ€ฆSee details»

Guilford Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...

Explore Guilford Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 6 news, and 133 literature, Disease Domain:Nervous System Diseases, Hemic and โ€ฆSee details»

Guilford Pharmaceuticals Inc. - careersinpharmaceutical.com

Guilford Pharmaceuticals Inc., is located at Baltimore, MD and is a biopharmaceutical company engaged in the research, development and commercialization of drugs that target the acute โ€ฆSee details»

Guilford Pharmaceuticals - Ownership and Business Overview

Guilford Pharmaceuticals was founded in 1993. Life Science M&A Summary in 2005 Out of 60 sectors in the Mergr database, life science ranked 13 in number of deals in 2005 .See details»

Guilford Pharmaceuticals: Two Acquisitions in Two Years

Dec 19, 1997 Guilford Pharmaceuticals, Inc., was a well established Baltimore biotech/pharma company when it was acquired in 2005 by Minnesota-based MGI Pharma, Inc., in a deal โ€ฆSee details»

Guilford Pharmaceuticals - Crunchbase Company Profile & Funding

Organization. Guilford Pharmaceuticals . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Guilford Pharmaceuticals. Private; 3,161,340; ... Who are โ€ฆSee details»

MGI PHARMA To Acquire Guilford Pharmaceuticals - Bioprocess โ€ฆ

Jul 21, 2005 Minneapolis, MN - MGI PHARMA, INC. an oncology and acute care focused biopharmaceutical company, and Guilford Pharmaceuticals Inc., a biopharmaceutical company โ€ฆSee details»

Guilford Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ

Apr 15, 2013 Guilford Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»

Guilford Pharmaceuticals, Inc. (Guilford Pharmaceuticals, Inc.) - ่ฏ โ€ฆ

ไบ†่งฃGuilford Pharmaceuticals, Inc. (Guilford Pharmaceuticals, Inc.)ๅ…ฌๅธ็š„่ฏ็‰ฉ็ฎก็บฟ๏ผŒๆฒป็–—้ข†ๅŸŸ๏ผŒๆŠ€ๆœฏๅนณๅฐ๏ผŒไปฅๅŠๅฎƒ็š„6็ฏ‡ๆ–ฐ้—ปๅ’Œ132็ฏ‡ๆ–‡็Œฎ๏ผŒ่ฏ็‰ฉ:GPI 15427๏ผŒPQ-1007๏ผŒGPI1511๏ผŒGPI โ€ฆSee details»

Guilford Pharmaceuticals Selects Evotec OAI as their Assay โ€ฆ

Guilford Pharmaceuticals Inc. is a fully integrated pharmaceutical company engaged in the research, development and commercialization of products that target the hospital market. โ€ฆSee details»

Minnesota biotech to buy Guilford Pharmaceuticals

Jul 20, 2005 MGI Pharma plans to buy Guilford Pharmaceuticals, which boasts two cancer drugs in its pipeline, in a deal worth about $177.5 million. Guilford is developing Giladel, a โ€ฆSee details»

Guilford Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Guilford Pharmaceuticals is a pharmaceutical company engaged in the research, development and commercialization of products that target the hospital market. Guilford's marketed โ€ฆSee details»

MGI Pharma To Buy Guilford - PharmTech

Jul 29, 2005 MGI Pharma (Minneapolis, MN) signed a merger agreement on July 20 to purchase Guilford Pharmaceuticals (Baltimore, MD) for approximately $177.5 million. MGI Pharma plans โ€ฆSee details»

MGI Pharma buys Guilford in $178M deal - Pharmaceutical โ€ฆ

Jul 24, 2005 MGI will acquire all of the outstanding shares of Guilford for $3.75 per share in a taxable merger. This consideration, which represents a premium of 55.6% over Guilford's โ€ฆSee details»

GUILDFORD PHARMACEUTICALS INC - Dun & Bradstreet

Pharmaceutical and Medicine Manufacturing Chemical Manufacturing Manufacturing Printer Friendly View Address: 6611 Tributary St Ste 100 Baltimore, MD, 21224-6539 United StatesSee details»

Guilford Pharmaceuticals Inc - careersinpharmaceutical.com

Address: 6611 Tributary St Baltimore, MD 21224 Phone: 410-631-6300 Company Information: Guilford Pharmaceuticals Inc. is a strategically driven innovator of novel pharmaceutical and โ€ฆSee details»

| BioWorld

Oct 5, 1993 Scios Nova Inc. announced Monday that it has formed a newcompany, Guilford Pharmaceuticals Inc., to discover, developand commercialize pharmaceuticals for diagnosing โ€ฆSee details»

BioPharmaLink profile of Guilford Pharmaceuticals Inc., United โ€ฆ

Guilford Pharmaceuticals Inc. Guilford Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development of novel products. Using its expertise in drug delivery and small โ€ฆSee details»

Guilford Pharmaceuticals Inc | www.inknowvation.com

State Support Organizations; Prof. Service Providers; Venture Capitalists; Academics; Analytics. About Analytics; State Office; Federal Agency Office; Tech Seekers (TS) ... Guilford โ€ฆSee details»

linkstock.net © 2022. All rights reserved